APA (7th ed.) Citation

D, N., TC, S., M, O., L, M., E, B., S, F., . . . F, F. (2025). Myeloid sarcoma shows a high frequency of mutations activating the MAPK/ERK pathway and association with clonal hematopoiesis. The journal of pathology. Clinical research, 11(5), e70044. https://doi.org/10.1002/2056-4538.70044

Chicago Style (17th ed.) Citation

D, Nann, et al. "Myeloid Sarcoma Shows a High Frequency of Mutations Activating the MAPK/ERK Pathway and Association with Clonal Hematopoiesis." The Journal of Pathology. Clinical Research 11, no. 5 (2025): e70044. https://doi.org/10.1002/2056-4538.70044.

MLA (9th ed.) Citation

D, Nann, et al. "Myeloid Sarcoma Shows a High Frequency of Mutations Activating the MAPK/ERK Pathway and Association with Clonal Hematopoiesis." The Journal of Pathology. Clinical Research, vol. 11, no. 5, 2025, p. e70044, https://doi.org/10.1002/2056-4538.70044.